Natural antibody-complement dependent neutralization of bovine herpesvirus 4 by human serum

Microbes and Infection

Volumn 9, Issue 14-15, 2007, Pages 1530-1537

  Machiels, Bénédicte ^a   Gillet, Laurent ^a   Nascimento Brito, Sieberth Do ^a   Drion, Pierre ^a   Delforge, Cédric ^a   Nizet, Yannick ^b   Gianello, Pierre ^b   Bona, Christophe ^a   Costes, Bérénice ^a   Markine Goriaynoff, Nicolas ^a   Vanderplasschen, Alain ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Bovine herpesvirus 4; Complement; Innate anti viral immunity; Natural antibodies; Virus neutralization

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; COMPLEMENT; EPITOPE; VIRUS ANTIBODY;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BOVINE HERPES VIRUS; CONTROLLED STUDY; COW; HERPES VIRUS; HOST RANGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SERUM; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, CLASSICAL; HERPESVIRUS 4, BOVINE; HUMANS; IMMUNE SERA; IMMUNITY, NATURAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTRALIZATION TESTS; TRISACCHARIDES; VERO CELLS;

ANIMALIA; BOVINAE; BOVINE HERPESVIRUS 4;

EID: 36849006964     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.08.007     Document Type: Article

References (30)

1. Zimmermann W., Broll H., Ehlers B., Buhk H.J., Rosenthal A., and Goltz M. Genome sequence of bovine herpesvirus 4, a bovine rhadinovirus, and identification of an origin of DNA replication. J. Virol. 75 (2001) 1186-1194
2. Egyed L. Replication of bovine herpesvirus type 4 in human cells in vitro. J. Clin. Microbiol. 36 (1998) 2109-2111
3. Donofrio G., Cavirani S., Simone T., and van Santen V.L. Potential of bovine herpesvirus 4 as a gene delivery vector. J. Virol. Methods. 101 (2002) 49-61
4. Gillet L., Minner F., Detry B., Farnir F., Willems L., Lambot M., Thiry E., Pastoret P.P., Schynts F., and Vanderplasschen A. Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis. J. Virol. 78 (2004) 2336-2347
5. Hunt R.D., Melendez L.V., Garcia F.G., and Trum B.F. Pathologic features of Herpesvirus ateles lymphoma in cotton-topped marmosets (Saguinus oedipus). J. Natl. Cancer. Inst. 49 (1972) 1631-1639
6. Fickenscher H., and Fleckenstein B. Herpesvirus saimiri. Philos Trans R Soc Lond, B, Biol Sci 356 (2001) 545-567
7. Bublot M., Dubuisson J., Van Bressem M.F., Danyi S., Pastoret P.P., and Thiry E. Antigenic and genomic identity between simian herpesvirus aotus type 2 and bovine herpesvirus type 4. J. Gen. Virol. 72 (1991) 715-719
8. Asher D.M. Bovine sera used in the manufacture of biologicals: current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies. Dev. Biol. Stand. 99 (1999) 41-44
9. Donofrio G., Flammini C.F., Scatozza F., and Cavirani S. Detection of bovine herpesvirus 4 (BoHV-4) DNA in the cell fraction of milk of dairy cattle with history of BoHV-4 infection. J. Clin. Microbiol. 38 (2000) 4668-4671
10. Wellenberg G.J., Verstraten E.R., Belak S., Verschuren S.B., Rijsewijk F.A., Peshev R., and Van Oirschot J.T. Detection of bovine herpesvirus 4 glycoprotein B and thymidine kinase DNA by PCR assays in bovine milk. J. Virol. Methods. 97 (2001) 101-112
11. Bona C., Dewals B., Wiggers L., Coudijzer K., Vanderplasschen A., and Gillet L. Short communication: pasteurization of milk abolishes bovine herpesvirus 4 infectivity. J. Dairy. Sci. 88 (2005) 3079-3083
12. Markine-Goriaynoff N., Minner F., De Fays K., Gillet L., Thiry E., Pastoret P.P., and Vanderplasschen A. Bovine herpesvirus 4. Ann. Med. Vet. 147 (2003) 215-247
13. Gillet L., Dewals B., Farnir F., de Leval L., and Vanderplasschen A. Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. Cancer. Res. 65 (2005) 9463-9472
14. Favoreel H.W., Van de Walle G.R., Nauwynck H.J., and Pensaert M.B. Virus complement evasion strategies. J. Gen. Virol. 84 (2003) 1-15
15. Welsh Jr. R.M., Cooper N.R., Jensen F.C., and Oldstone M.B. Human serum lyses RNA tumour viruses. Nature 257 (1975) 612-614
16. Galili U., Clark M.R., Shohet S.B., Buehler J., and Macher B.A. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1-3Gal epitope in primates. Proc. Natl. Acad. Sci. U.S.A 84 (1987) 1369-1373
17. Teranishi K., Manez R., Awwad M., and Cooper D.K. Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates. Xenotransplantation 9 (2002) 148-154
18. Welsh R.M., O'Donnell C.L., Reed D.J., and Rother R.P. Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses. J. Virol. 72 (1998) 4650-4656
19. Hayashi S., Takashima Y., and Otsuka H. Pseudorabies virus propagated in rabbit kidney-derived RK13 cells is neutralized by natural IgM antibodies in normal swine serum which specifically lyse host cells. J. Vet. Med. Sci. 67 (2005) 229-234
20. Jayasekera J.P., Moseman E.A., and Carroll M.C. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol. 81 (2007) 3487-3494
21. Quinn G., Wood J.C., Ryan D.J., Suling K.M., Moran K.M., Kolber-Simonds D.L., Greenstein J.L., Schuurman H.J., Hawley R.J., and Patience C. Porcine endogenous retrovirus transmission characteristics of galactose alpha1-3 galactose-deficient pig cells. J. Virol. 78 (2004) 5805-5811
22. Takeuchi Y., Liong S.H., Bieniasz P.D., Jager U., Porter C.D., Friedman T., McClure M.O., and Weiss R.A. Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl (alpha1-3) galactosylation. J. Virol. 71 (1997) 6174-6178
23. Schroeder H., Daix V., Gillet L., Renauld J.C., and Vanderplasschen A. The paralogous salivary anti-complement proteins IRAC I and IRAC II encoded by Ixodes ricinus ticks have broad and complementary inhibitory activities against the complement of different host species. Microbes. Infect. 9 (2007) 247-250
24. Daix V., Schroeder H., Praet N., Georgin J.P., Chiappino I., Gillet L., de Fays K., Decrem Y., Leboulle G., Godfroid E., Bollen A., Pastoret P.P., Gern L., Sharp P.M., and Vanderplasschen A. Ixodes ticks belonging to the Ixodes ricinus complex encode a family of anticomplement proteins. Insect. Mol. Biol. (2007)
25. Dewals B., Gillet L., Gerdes T., Taracha E.L., Thiry E., and Vanderplasschen A. Antibodies against bovine herpesvirus 4 are highly prevalent in wild African buffaloes throughout eastern and southern Africa. Vet. Microbiol. 110 (2005) 209-220
26. Shaw D.R., Shaw M.W., Hickman S.E., Lamon E.W., and Griffin Jr. F.M. Sodium azide inhibition of complement-mediated functions. Immunology 39 (1980) 53-56
27. Vanderplasschen A., Mathew E., Hollinshead M., Sim R.B., and Smith G.L. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. U.S.A 95 (1998) 7544-7549
28. Vanderplasschen A., Bublot M., Dubuisson J., Pastoret P.P., and Thiry E. Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface. Virology 196 (1993) 232-240
29. Hamadeh R.M., Galili U., Zhou P., and Griffiss J.M. Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin. Diagn. Lab. Immunol. 2 (1995) 125-131
30. Abdel-Motal U., Wang S., Lu S., Wigglesworth K., and Galili U. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes. J. Virol. 80 (2006) 6943-6951